Renal Cancer - Results from #1020

Prevalence of germline mutations in cancer susceptibility genes in Chinese patients with renal cell carcinoma. March 20, 2023

Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer. March 20, 2023

Impact of Overweight and Obesity on U.S. Renal Cell Carcinoma Incidence Trends (1995-2018). March 20, 2023

Risks and benefits of partial nephrectomy with limited or without ischemia time. March 20, 2023

Cytoreductive partial and radical nephrectomies provide equivalent oncologic outcomes in T1-2M1 renal cell carcinoma. March 17, 2023

Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and Prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study. March 17, 2023

Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19. March 16, 2023

Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy. March 16, 2023

Estimated Direct Costs of Renal Cancer by Stage of Disease at Diagnosis and Phase of Its Management: A Whole-Disease Model. March 15, 2023

Multiparametric magnetic resonance imaging for characterizing renal tumors: A validation study of the algorithm presented by Cornelis et al. March 15, 2023

The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm. March 14, 2023

Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer. March 14, 2023

B7-H3 expression is associated with high PD-L1 expression in clear cell renal cell carcinoma and predicts poor prognosis. March 13, 2023

Transcriptome mapping of renal clear cell carcinoma revealed by machine learning algorithm based on enhanced CT images. March 13, 2023

Superiority of magnetic resonance imaging in small renal mass diagnosis where image reports mismatches between computed tomography and magnetic resonance imaging. March 10, 2023

Diagnostic Imaging in the Evaluation of Asymptomatic Microhematuria: Systematic Review and Meta-Analysis. March 10, 2023

Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients. March 9, 2023

The effect of perioperative blood transfusion on survival after renal cell carcinoma nephrectomy: A systematic review and meta-analysis. March 9, 2023

The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery. March 8, 2023

Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era. March 8, 2023

Page 52 of 456